Incendia Therapeutics

Half of all human cancers naturally build a protective barrier that repels the body’s healthy immune cells from entering. Parthenon is creating anti-cancer therapies that reprogram the tumor microenvironment to break down these protective barriers to overcome recalcitrant cancers.